Catheter Antitrust Claims Against CR Bard Nixed

Law360, New York (September 28, 2009, 5:09 PM EDT) -- A federal judge has tossed out antitrust claims against medical technology manufacturer C.R. Bard Inc., accused by hospitals of hatching a scheme that purportedly drove up prices of urological catheters.

Judge Thomas C. Mummert III threw out what was left of the case and granted Bard's motion for summary judgment on Monday in the U.S. District Court for the Eastern District of Missouri, saying it was the plaintiffs who were at issue, not urological products manufacturers.

“There is no genuine issue that the antitrust violations alleged...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.